Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Sokos

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Palliative Medicine|October 11, 2014
Use of home inotropes in patients near the end of life #283Mallory Strickland Ciuksza, Randy Hebert, George Sokos
Clinical Cardiology|November 18, 2018
Utilization of palliative care in patients hospitalized with heart failure: A contemporary national perspectiveFahad Alqahtani, Sudarshan Balla, Ahmad Almustafa, et al.
The Annals of Pharmacotherapy|January 1, 2021
Evaluating Sacubitril/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection FractionKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
Journal of the American Pharmacists Association : Japha|December 16, 2024
Implementing a telemedicine-led heart failure medication regimen optimization clinic in medically underserved heart failure populationsKazuhiko Kido, Wei Fang, Kimberly Becher, et al.
Journal of the American Pharmacists Association : Japha|October 5, 2023
Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapyKazuhiko Kido, Brittany Carey, Marco Caccamo, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2021
Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/ValsartanKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
Journal of Pharmacy Practice|May 16, 2023
Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection FractionKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
The Annals of Pharmacotherapy|August 9, 2012
Safe use of hemodialysis for dabigatran removal before cardiac surgeryMatthew R Wanek, Edward T Horn, Subbarao Elapavaluru, et al.
The Annals of Pharmacotherapy|February 16, 2022
Economic Impact of Ambulatory Clinical Pharmacists in an Advanced Heart Failure ClinicKazuhiko Kido, Bailey M Colvin, Rachael Broscious, et al.
Pulmonary Circulation|May 11, 2013
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertensionAmresh Raina, James C Coons, Manreet Kanwar, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Palliative Medicine|October 11, 2014
Use of home inotropes in patients near the end of life #283Mallory Strickland Ciuksza, Randy Hebert, George Sokos
Clinical Cardiology|November 18, 2018
Utilization of palliative care in patients hospitalized with heart failure: A contemporary national perspectiveFahad Alqahtani, Sudarshan Balla, Ahmad Almustafa, et al.
The Annals of Pharmacotherapy|January 1, 2021
Evaluating Sacubitril/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection FractionKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
Journal of the American Pharmacists Association : Japha|December 16, 2024
Implementing a telemedicine-led heart failure medication regimen optimization clinic in medically underserved heart failure populationsKazuhiko Kido, Wei Fang, Kimberly Becher, et al.
Journal of the American Pharmacists Association : Japha|October 5, 2023
Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapyKazuhiko Kido, Brittany Carey, Marco Caccamo, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2021
Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/ValsartanKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
Journal of Pharmacy Practice|May 16, 2023
Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection FractionKazuhiko Kido, Christopher Bianco, Marco Caccamo, et al.
The Annals of Pharmacotherapy|August 9, 2012
Safe use of hemodialysis for dabigatran removal before cardiac surgeryMatthew R Wanek, Edward T Horn, Subbarao Elapavaluru, et al.
The Annals of Pharmacotherapy|February 16, 2022
Economic Impact of Ambulatory Clinical Pharmacists in an Advanced Heart Failure ClinicKazuhiko Kido, Bailey M Colvin, Rachael Broscious, et al.
Pulmonary Circulation|May 11, 2013
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertensionAmresh Raina, James C Coons, Manreet Kanwar, et al.
Pageof 5